Autoimmune and autoinflammatory arthritis are often called "invisible illnesses" because many patients may appear healthy on the outside while silently battling chronic pain, fatigue, stiffness, and ...

AbbVie (ABBV) stock is in focus as UCB's Bimzelx beats the company's immunology blockbuster Skyrizi in head-to-head trial for ...

Arthritis can limit daily activities, but the Aging Untold experts say there are effective ways to manage symptoms and ...

Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...

Doctors share common rheumatoid arthritis symptoms, from wrist pain and swollen joints to fatigue, dry eyes, and skin nodules ...

Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

BMS has secured approval from the European Commission for Sotyktu (deucravacitinib) to treat active psoriatic arthritis (PsA).

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...

Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...